The Deal
Saturday, November 21, 
1:14 am

Bloomberg: Ackman's Target investment not on target

  Share     E-Mail    Discussion (1)     Print Story
William_Ackman_of_Pershing_Square.jpgActivist hedge fund manager William Ackman of Pershing Square Capital Management LP appears to have had a mixed 2008, which is more than can be said for most of his peers. In 2008 he had some losses, which he can thank to investments in retailers, but he also had some winning bets, including an unlikely one.

Continue reading below

Also on Dealscape

The often vocal activist did not have a good word for investors about his fund's Target Corp. holding, as the Pershing fund that invests in the Minneapolis-based retail giant fell 68% in 2008, according to a letter to investors, as reported late Monday by Bloomberg. The fund's decline eclipsed the retailer's share price loss of about 31% over the past year.

Pershing in the summer of 2007 raised a $2 billion special purpose vehicle in nine days to invest in a corporation without having to inform investors of the target or plan. That target turned out to be Target. Pershing owns about 9.5% of Target's shares through the special purpose vehicle. Bloomberg reported that the vehicle's 2008 loss followed a 43% decline in 2007, adding that the fund is structured so its returns double Target's stock movement.

The hits Pershing took on Target were not for a lack of trying to boost shares. Bowing to pressure from Pershing, Target in May agreed to sell an interest in its credit card business to J.P. Morgan Chase & Co. for $3.6 billion. Its shares barely budged following the news, closing up less that 0.5% on May 6 at $53.44. Target's shares finished 2008 at $34.53.

Ackman continues to soldier on to try to salvage his Target investment. On Nov. 19, he released a 79-page proposal that called for Target to form a REIT that would own the land under its owned stores and spin off 20% of that REIT in an initial public offering. He predicted that a REIT spinoff could help unlock the value of Target's real estate and lift its shares to about $79 by 2010. Shareholders did not seem to buy into Ackman's plan as Target's stock skidded about 14.5% on Nov. 19.

Despite the bad news at Target -- and the even worse news at Borders Group Inc., another Pershing investment -- the retail world has not been all bad for the firm. In fact in an odd twist, the firm made a killing on its investment in Longs Drug Stores Corp., which was sold in late October to CVS Caremark Corp.

According to an Aug. 5 13D filing to the SEC, Pershing acquired a roughly 8.8% stake in Longs in common stock between the end of June and the end of July, paying between $40.47 and $45.92 per share. He increased his stake to 23.6% through total return swap arrangements, which allowed him to boost his returns on his initial 8.8% investment of about $136.6 million. Ackman opposed the acquisition, saying it undervalued Longs, and Walgreens Co. stepped in in September with a competing $75 per share bid. When all was said and done, the CVS $71.50 per share acquisition was completed, and Ackman, despite his opposition, walked away with about $660 million.

Longs worked out for Ackman as did his short positions. Two of his more highly publicized short positions, battered bond insurers MBIA Inc. and Ambac Financial Group Inc., fell about 79% and 95% in 2008, respectively. Details on his positions in these two companies could not be ascertained. - Michael Rudnick





Comments

From: Ruud,

Investors in Pershing Square should be concerned about Ackman closing out this fund like he did with his first fund - Gotham Partners - at huge losses to investors.


Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: Avaya Inc.'s Mohamad Ali on the company's next target.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Managing your shareholder base

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


Industry Insight

Easing the stress of distressed M&A

Corporate buyers face numerous complexities when trying to identify the right moment to purchase a distressed asset.


Editor's Note

Editor's letter: Nov. 16, 2009

Beneath the veneer of Wall Streeters beats the same heart, stirred by the same determinants of behavior.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.